[Cytoflavin in the treatment of preschool and early school age children with the consequences of perinatal hypoxic brain damages].

Aim: To study the efficacy and safety of the complex metabolic neuroprotector cytoflavin in children with the consequences of perinatal hypoxic brain damages.

Material And Methods: Patients, aged 4-8 years, were stratified into three groups: 35 with infant cerebral palsy, 64 with the minimal brain dysfunction and 47 with sensorineural hearing loss. The control group consisted of 30 children.

[Correction of central nervous system energy processes in children with the minimal cerebral dysfunction].

Clinical-neurophysiological investigation of the efficiency of complex metabolic neuroprotector Cytoflavin in monotherapy was performed in 64 children of 4-8 years old with the minimal cerebral dysfunction. During the treatment other preparations were not used. Neurologic status, neurophysiological inspection, neuropsychophysiological and speech testing were performed before and after the course of treatment.

[Clinical, neurophysiologic and neuropsychophysiologic aspects of spastic forms of infant cerebral palsy in children of preschool and early school age.].

Clinical, neurophysiologic and neuropsychophysiologic study has been conducted in 120 children with spastic forms of infant cerebral palsy (ICP) at the age 5-8 years. Developmental features and rates of the higher mental functions (HMF) have been investigated during medical-rehabilitation measures. The original complex of neuropsychophysiological testing programs allows to quantitatively and qualitatively estimate a degree of HMF development in children.